The B-cell–receptor signaling pathway plays a key role in the pathogenesis of Chronic Lymphocytic Leukemia (CLL) and signaling is mediated in part by the activation of the delta isoform of phosphatidylinositol 3-kinase (PI3Kdelta), which... [Learn More...]

The post Idelalisib: Could This ‘B’ the Ideal Treatment For Chronic Lymphocytic Leukemia (CLL)? appeared first on CTOAM.